Member Info for Atanasoff

"The more Deckhand posts, the more I think company has a stronger case."

That says more about you than it does about him.

"If company didn't understand contract or if it was more one sided towards government then surely this makes it unfair and unenforceable."

How to say you have no business experience without saying you have no business experience.

You may be interested in understanding the Unfair Contract Terms Act (UTCA) 1977. Other contract related clauses can be found in the Sales of Goods Act 1979 and the Supply of Goods and Services Act (SGSA) 1982 although in this matter it is unlikely to reply.

In the UTCA you have various clauses that would represent unfairness. It could be argued that ODX may choose to use some of these should the matter proceed to litigation. I am not a solicitor or barrister, however, I work in this orbit.

It is not good enough to use the "but he made me do it" or the "I'm too thick to understand what I was getting into" when it comes to a listed company, unless the directors wish to have their ability to carry out their fiduciary duties questioned.

The contract was clear. The fact ODX got carried away is also pretty clear. The segmentation of funds is crucial here. Election year may or may not be of benefit to them. Pipe dream to think they will get millions of pounds in settlement and the ABDX case is very different.

"Add to that government machinery was stored in premises, and company had reduced production on their food sensitivity product. Makes it more unfair."

That is just about the silliest argument I have ever seen. Well done. (Here's a clue as you STILL seem to know nothing about the company - Food sensitivity testing was produced in volume at the Alva site.)

" I think at worse case scenario the £2.5m will not have to be paid back. "

I am glad you finally agree with me. This to me is best case scenario.

"Further compensation would be a bigger bonus, which is what the company are still saying. It's in the RNS."

The company says many things in RNS. Many of these things are worse ramping rubbish than the alleged criminal posts on here.

Calderkate

I dont think you have any right to call anyone else a "sad individual". Go take a look in the mirror. A spamming nobody with all the intellect of a startled pheasant.

Anyone that doen't agree with you would be classed as condescending because you're a fundamentally dreadful person and it is very challenging not responding to you as the intellectual pigmy you clearly are.

You seem obsessed by me but as usual you read what you think I have written rather than what I have written. This cognitive deficiency is your problem and I am not going to spend my time correcting it. I am not sure what you mean by "win" as I that isn't what a discussion board is about. As I have stated I have no financial interest in CNSL. It is purely for fun that I post. Only an idiot would currently be heavily invested in this stock in my view.

Your opinion is wrong because it relies on hope and gullibility over evidence and experience. You're too arrogant to learn anything from people that have more experience than you and too lazy to do any research or learn how to read a P&L. Instead if you think something you automatically assume it is correct. You have something called the dunning=kruger effect. It is common for those, such as yourself, who have limited educational achievement. This is your loss and something I find amusing.

My prediction stands - this is going to be 2.25p. I suggested it may happen before the year end but that wasn't a prediction. Anyone with the mental agility above that of a mollusc would be able to grasp the difference.

toodle pip.

My posts haven't changed - still one of the only ones posting actual research - something you never do.

Secondly - as you're downright paranoid and a conspiracy theory loon I can confirm I have not had my knuckles or anything else rapped.

Keep up with your delusions. They are hilarious. You've become a parody of yourself.

I never lie. I have no need to. Go look in the mirror.

Yes you were green binned but due to your prolific and clueless posting and online bullying. I fancied some comedy. Thanks for delivering. Your paranoid bleatings are priceless.

Never actually address any points or learn anything- just make false accusations and make stuff up. What makes it funny is if you just stopped for a second and put that brain cell to work even you would realise how totally crazy they are.

I will no doubt green bin you when you go through your next spamming angry stage. Which should be fairly soon based on your dreadful form.

I would wish you a pleasant day but I wouldn’t mean it. So I won’t.

Clueless Kate strikes again.

I have a bridge to sell to the worlds most gullible person on AIM.

It is now over 4 months since Chris Lea, the credible CFO brought on board by CNSL, jumped ship.

As I said at the time losing a CFO is bad news in most cases. His departure also indicated that no M&A was likely as that is an area he specialised in. Since he left ( 22 Aug 2023 07:00, RNS Number : 9840J) the share price has done nothing. Get used to that holders in my opinion.

The microbiome market, despite the uncertainties is showing good promise. ZOE and the likes of Henry Dimbleby and Prof Tim Spector are leading the way with highlighting this relatively new and undiscovered area of science. It should be a surprise that lots of VC money has poured into companies that are credible.

One such company is Enterbiotix is one UK company that has now started clinical trials. It has a strong board led by doctors and scientists rather than track suit wearing chancers with a chair that has all the energy levels of a whelk.

Guess who is the new CFO?

Step forward Chris Lea.

The problem with this area of medicine is that serious products need serious investment. EBX got $21 million in Series A funding whereas CNSL/ODX couldn't even secure an overdraft facility. Because it is relatively "new" it also means the market is a race for proven, credible products to enter a market that will, due to the potential, a crowded market.

Just as a reminder. CNSL do not have a test - that is why they have announced they will white label someone uses product.

I wish Chris all the very best in his new role in a company that looks like it has the skills and resource to deliver.

Meanwhile, CNSL haven't even got around to appointing a new CFO. This means it lacks significant skill, expertise and strategic guidance in the boardroom. But you know this already.

Tally Ho.

As with everything SYME related some of you need to read to the end of the RNS and then get a grown up to explain what it means.

I love watching this share. It’s the gift that keeps on giving (to Alex).

I do wonder if calderkate actually thinks she is a good person. Spouts about golden rules but is a passive aggressive bully.

Possibly the most vile poster I’ve ever come across.

Looking at the markets today almost everything is up based on the feds announcement. One of my stocks is up nearly 10%.

CNSL not so much. A dog is a dog and this is a zombie stock.

It only seems hard to comprehend for some that spend all day here insulting and attacking others. It is as though they have an agenda

Captain

It is ironic that it is only us two that post any information about this business. The spammers only repeat headlines from RNS or attack us. It is staggering that they spend so much time on disinformation.

They NEVER respond to research and never debate. Just spam and attack

They have their reasons I guess. It is pretty tragic but there you are.

Meanwhile - the sell off continues. Back to 2.25p by end of year?

Oh look the green stripe has replied? What does it say? I dont know. Like life, it is crying into the wind with no one noticing or caring.

Perhaps it is pretending to have success. But that is like being so stupid as to think an RNS headlines can be believed. The reality is very different.

If only it would listen for once. But no, losers never do.

LOLZ.

Back to being a green stripe Calderkate. Tried to give you guidance. My judgement of you was spot on. Its hilarious.

Calder Kate

I realise you do like a conspiracy theory but as I have stated numerous times I have zero connection with ODX /CNSL or in the sort of snake oil test they sell.

Hope that clears that up once and for all - of course it won’t because it’s you and you have form.

As I am on holiday and I cant be bothered to do anything I thought it would be nice to unblock the green stripe. Here is me giving you something gratis:

I will try and make this simple for you:

1) Revenue is vanity, profit is sanity.

2) £2.4 million was carried from the last financial year. Accounting for usual carry over between financial years the uplift was around £1.2m due to production issues. In other words, this would have been in the previous years accounts if they hadn't failed to get the ISO accreditation and processes in place that every single other medical company I know uses.

3) This means that the accounts are not as rosey - in fact they are flat lining as a whole. This should ring alarm bells when the growth in domestic markets are considered , because.....

4) ) In the presentation Jag let slip that the UK is now considered saturated. It was a blink and you miss it comment. I have been hinting at this since then but you all missed it.

5) This means that they must rely on US and China for growth and although some elements were positive in context of macro economic factors it isn't the rosey picture being painted.

6) The other fact is that in 2018 ODX had 3 US clients and they now have one with another one (which strangely wasn't mentioned) in the validation/testing stage. The much promised US targeting has never really got going because they do not commit the needed funds and resource at it.

7) By the board admission revenue will decline in H2. Let's say it keeps on track with previous years cycles it will mean that for year end the revenue will not have recovered to what it was for this division.

8) The good news is that cash burn has significantly decreased. But this is still an issue. If revenue is going to decline, as announced, then so will profit. Even with an uplift in GM the effect will be a higher proportion of cash burn (obviously lower material costs as they will be making less but bottom line costs are relatively static).

9) This means that on project we can expect the cash balance to be £3.6-£3.8m at the end of march.

This is not a miracle stock. Business rarely is. Growth takes time, patience, skill and a bunch of luck.

If you want to really understand this stock you will look at other medical companies in AIM that were caught in the COVID mess. ABDX is a good one. Look at the fundamentals and the currently market cap and then compare to CNSL. If you do and look at the above objectively you will work out that the share price is likely to settle at 2.25p.

Positive news from settlement and sustained growth may temporarily give it a rise to circa 3.5p but the RNS and the shareholders votes mean that this will not go above 4p IMO for a good while and if it does the board will gladly dilute it to hell again.

You would be better cashing out and putting it in a high savings account currently. OR keeping it but then trading it on the next P&D.

Just dont expect miracles.

Hope that h

"That is why Labour will appoint a [commissioner] to go through pandemic contracts line by line and whenever they have failed to deliver, we will clawback every pound we can for the public.”

Rachel Reeves

Although, due to incompetence and a frankly ludicrous test validation system ODX didn't reap the rewards that the likes of the dispicable Baroness Mone did, the ODX contract still meant that £2.5 million of tax payers money is under dispute. ODX delivered near nothing and the BoD clearly read the contract incorrectly.

ODX didnt even realise the contract had been cancelled, such is the dire management of the company. Since then they have been in dispute. For the record I do not believe they will need to pay back much or any of the money - meaning that money that could be better spent in the NHS or for those most in need will not be fulfilled.

But this is a timely reminder that time is running out. A new broom in government will want to show they are hitting the ground running. The first 100 days is crucial for a government. So when this government falls expect the next one to be tougher in negotiations and more engaged at bringing matters to a positive conclusion for the hard working tax payer.

To an extent I agree Gazza

However the biggest issue with ODX is two fold:

1) They got carried away, made a bunch of money and forgot to read the contract

2) They seem to be taking as gospel what a solicitor /barrister team is telling them.

One thing to watch for in the end of year results next year will be how much they have paid in professional fee's. Compare that to previous years. Billing soon mounts up and is a veritable cash cow for those in commercial litigation. (I'm not a solicitor or barrister but work in related field and I bill by the minute)

I find ODX hilarious. It's addictively rubbish.

Another day of more posts than trades. The fact is that volume is now almost at levels not seen through the barren summer months. Despite the attacks some of us know what happens next.

In the meantime the trades today barely cover a moderate weekend away:

# Trades 5

Vol. Sold 103,378

Sold Value £2.59k

Vol. Bought 25,841

LOLZ

Lolz

The ramp is over. Barely any volume. Ropey IGG tests only producing 2022 revenues. No one wanting to be reminded the board were ramping the US as a major target market back in 2017 - but has less lab clients.

This stock never fails to fail no matter how many times those deeply under water want to delete the evidence

They didn't go from £2.7 to £4.4m. That is a fundamentally false statement.

They got £6m for the sale of the "Crown Jewels" in their portfolio. They also raised a further £2m from the (last) dilution (remember the warrants you were claiming would rocket the share price once they expired?). They also had other balances (although it was touch and go - you people don't realise how close they got to going bust).

This company is fantastic at spending money.

Now, even for some sub prime illiterate that adds up to more that £4.4m. It got spent because they spend more than the earn. That is why we can say with some confidence that on current burn rates the balance will be circa £3.8m by March 31st 2024.

Here endeth the lesson.